Latest filing published 09 Aug 2021 for Rossari Biotech Limited, €8,041.
Filing timeline
BuySaleYogesh Linge: trading record in brief
Yogesh Linge is a declared insider of Rossari Biotech Limited (chief executive), with filings sourced from SEBI (PIT + SAST). We count 3 filings; the first trade dates from 17 July 2021 and the latest from 6 August 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 9 August 2021 came the latest disclosure, a transaction for €8,041 in Rossari Biotech Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 2 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Yogesh Linge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ ₹1,411.000.0000% mcap22.4% of flowEquity SharesSEBI:7ff869b1530242843c1f930954ceda8e2746ed1f
- 1,000 shares@ ₹1,289.550.0001% mcap40.7% of flowEquity SharesSEBI:18bc351b5aa83bad0ea39233fef561ad39c810a1
- 1,000 shares@ ₹1,167.450.0001% mcap36.9% of flowEquity SharesSEBI:4a30a18fef52169d5846889a74161640582f3e1fCanonical exit: 15 Oct 2021 (T+90)
3 of 3 declarations